Marantic endocarditis, also known as non-bacterial thrombotic endocarditis (NBTE), is a rare but life-threatening condition characterized by the formation of sterile blood clots on heart valves. It is frequently associated with advanced malignancies, such as lung adenocarcinoma, and often presents as an acute ischaemic stroke due to the embolization of these clots to the brain.
What Is Marantic Endocarditis?
Marantic endocarditis involves the development of vegetations—small, sterile growths composed of platelets and fibrin—on cardiac valves. Unlike infectious endocarditis, these growths do not contain bacteria. According to the American Heart Association, these vegetations are friable, meaning they break off easily and enter the bloodstream.
In patients with systemic diseases like cancer, the body enters a hypercoagulable state—a condition where the blood is more prone to clotting. Lung adenocarcinoma, a common form of non-small cell lung cancer, is particularly linked to this phenomenon because tumor cells can release substances that activate the coagulation cascade, leading to the formation of these valve vegetations.
Why Does It Cause Ischaemic Stroke?
The primary clinical danger of NBTE is systemic embolization. When a vegetation detaches from a heart valve, it travels through the circulatory system. If this clot reaches the cerebral arteries, it blocks blood flow to the brain, causing an ischaemic stroke.
Clinical data published in StatPearls highlights that patients with unexplained stroke, particularly those with a history of malignancy, should be evaluated for hypercoagulable states. Because the vegetations are small and lack the inflammatory characteristics of bacterial infections, they are often difficult to detect on standard imaging, requiring high-resolution echocardiography, such as a transesophageal echocardiogram (TEE), to visualize.
Key Takeaways for Clinical Recognition
- Hypercoagulability: Cancer patients are at an elevated risk for thrombotic events due to the underlying malignancy.
- Valve Involvement: The mitral and aortic valves are the most common sites for non-bacterial vegetation formation.
- Stroke Presentation: An ischaemic stroke in a cancer patient may be the first clinical manifestation of underlying NBTE, rather than a primary neurological event.
- Diagnostic Challenges: Transthoracic echocardiograms often miss these small, sterile vegetations; TEE is the gold standard for diagnosis.
How Is It Managed?
Management of marantic endocarditis is twofold: treating the underlying cancer and preventing further embolization. According to guidelines from the European Society of Cardiology, anticoagulation therapy—typically using low-molecular-weight heparin—is the mainstay of treatment to prevent further clot formation.
While surgical intervention to remove vegetations is possible, it is rarely the first line of treatment because the patient’s overall prognosis is often determined by the stage and aggressiveness of the underlying malignancy. Physicians focus on systemic anticoagulation and oncology-directed therapy to stabilize the patient’s hypercoagulable state.
Frequently Asked Questions
Is marantic endocarditis an infection?
No. It is a non-infectious, sterile condition caused by the deposition of blood components like platelets and fibrin on heart valves.
Why is lung cancer associated with this condition?
Lung adenocarcinoma can trigger a systemic hypercoagulable state through the release of pro-coagulant factors, which increases the likelihood of abnormal clot formation throughout the body.
Can it be cured?
Treatment focuses on managing the primary cancer and using anticoagulants to prevent further stroke. The long-term outlook depends heavily on the response of the cancer to chemotherapy or other targeted treatments.
Keep reading